Medicine
Vasostrict 20 units/mL injection
Vasostrict 20 units/mL injection is a prescription medicine containing Vasopressin, unspecified for intravenous use, marketed by Par Health, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. Vials may be held up to 12 months upon removal from…
Key facts
- Active ingredient (INN)
- Vasopressin, unspecified
- Brand
- Vasostrict
- Strength
- 20 units/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials, 25 vials, 1 vial and 3 more
- Marketing authorisation holder
- Par Health
- Manufacturers
- Par HealthMedical Purchasin SolutionsMedical Purchasing Solutions
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Vials may be held up to 12 months upon removal from refrigeration to room temperature storage conditions (20°C to 25°C [68°F to 77°F], USP Controlled Room Temperature), anytime within the labeled shelf life. Once removed from refrigeration, unopened vial should be marked to indicate the revised 12 month expiration date. Store between 2°C and 8°C (36°F and 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 November 2014
- Identifiers
- RxCUI 313578, 1593738, 2103182 +7DailyMed set ID b1147beb-743e-4c62-8927-91192447f8b8, 6672a5c9-bcfd-d7fc-e053-2991aa0aef88, d162d386-105d-e916-e053-2995a90a350c +1NDC 42023-190, 42023-164, 71872-7014 +1Application NDA204485
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 1 mL in 1 vial | 42023-164-10 | Par Health | 17 August 2020 |
| 25 vial in 1 carton / 1 mL in 1 vial | 42023-164-25 | Par Health | 12 November 2014 |
| 25 vial in 1 carton / 1 mL in 1 vial | 42023-164-83 | Par Health | 5 December 2022 |
| 1 vial in 1 carton / 10 mL in 1 vial | 42023-190-01 | Par Health | 27 February 2017 |
| 1 vial in 1 bag / 1 mL in 1 vial | 71872-7014-1 | Medical Purchasin Solutions | 28 February 2018 |
| 1 vial in 1 bag / 1 mL in 1 vial | 71872-7264-1 | Medical Purchasing Solutions | 19 August 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vasopressin, unspecified 20 units/mL injection.
Other strengths and forms of Vasopressin, unspecified
Clinical summary
Vasopressin, unspecified is a prescription medicine indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It is available as injection for intravenous use. MedsAcross supplies Vasopressin, unspecified for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Vasopressin, unspecifiedFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vasostrict prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
Need Vasostrict 20 units/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.